Table 4 Results of Ultrasound, Liver stiffness measurement (LSM) and Controlled Attenuation parameter (CAP) at baseline (n = 107).

From: Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study

Characteristic

Number (percent)

Ultrasound grades of Fatty Liver

Grade 1

24 (22.43)

Grade II

66 (61.68)

Grade III

17 (15.88)

Liver stiffness measurement (LSM), kPa

 < 7.0 (F1)

25 (27.10)

7.0–8.6 (F2)

38 (42.05)

8.7–11.5 (F3)

28 (30.84)

Controlled Attenuation parameter (CAP), dB/m

223–310 (S1)

14 (14.95)

311–339 (S2)

48 (53.27)

 > 340 (S3)

29 (31.77)

  1. n = 91.